Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for RIGL stock have an average target of 58.13, with a low estimate of 12.5 and a high estimate of 150. The average target predicts an increase of 501.76% from the current stock price of 9.66.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$12.5	$58.13	$40	$150
Change	+29.40%	+501.76%	+314.08%	+1452.8%

Analyst Ratings

The average analyst rating for RIGL stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '24	Mar '24	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	1	3	3	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	5	5	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $150	Strong Buy	Reiterates	$150	+1,452.80%	Jun 25, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $150	Strong Buy	Reiterates	$150	+1,452.80%	Jun 17, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $150	Strong Buy	Reiterates	$150	+1,452.80%	Jun 3, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $150	Strong Buy	Reiterates	$150	+1,452.80%	May 8, 2024
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $30 → $40	Strong Buy	Maintains	$30 → $40	+314.08%	Mar 7, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

152.10M

Increased by 30.13%

from 116.88M

Revenue Next Year

194.98M

Increased by 28.19%

from 152.10M

EPS This Year

-0.09

from -1.40

EPS Next Year

0.06

from -0.09

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	59.29M	108.62M	149.24M	120.24M	116.88M	152.10M	194.98M	230.29M	259.64M	290.21M
Revenue Growth	33.20%	83.21%	37.39%	-19.43%	-2.79%	30.13%	28.19%	18.11%	12.74%	11.77%
EPS	-4.00	-1.80	-1.10	-3.40	-1.40	-0.09	0.06	0.21	0.34	0.39
EPS Growth	-	-	-	-	-	-	-	235.74%	61.13%	15.15%
Forward PE	-	-	-	-	-	-	155.26	46.24	28.70	24.92
No. Analysts	-	-	-	-	-	8	8	8	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	168.2M	226.1M	276.5M	283.5M	321.0M
Avg	152.1M	195.0M	230.3M	259.6M	290.2M
Low	124.4M	156.8M	195.9M	228.9M	248.3M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	43.9%	48.7%	41.8%	23.1%	23.6%
Avg	30.1%	28.2%	18.1%	12.7%	11.8%
Low	6.4%	3.1%	0.5%	-0.6%	-4.4%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	0.05	0.15	0.40	0.40	0.41
Avg	-0.09	0.06	0.21	0.34	0.39
Low	-0.18	-0.07	0.09	0.27	0.36

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	548.0%	91.0%	21.7%
Avg	-	-	235.7%	61.1%	15.2%
Low	-	-	41.8%	31.4%	7.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.